Rep. Tom Suozzi, a Democratic congressman from New York, has built a public record as an advocate for China's Uyghur minority, co-sponsoring major legislation and leading a bipartisan caucus dedicated to the persecuted group. However, according to congressional financial disclosure reports reviewed by Political Bytes, Suozzi simultaneously held investments in Chinese companies whose supply chains and technologies have faced scrutiny over alleged connections to Uyghur forced labor and surveillance.
The Uyghurs are a predominantly Muslim, Turkic-speaking ethnic minority in China's Xinjiang region whom human rights organizations have accused the Chinese Communist Party of subjecting to mass detention, forced labor, and other abuses. Suozzi's advocacy dates back to March 2020, when he co-sponsored the Uyghur Forced Labor Prevention Act, which President Joe Biden later signed into law.
What the Right Is Saying
Republican critics say Suozzi's trading activity illustrates a double standard between his public advocacy and private financial decisions. Conservative commentators have pointed to the timing of his NIO purchases, made within months of co-sponsoring legislation targeting forced labor in Xinjiang.
House Republican leaders have pushed for broader ethics reforms addressing stock trading by members. Rep. Bryan Steil (R-WI) introduced the "Stop Insider Trading Act" earlier this year, which would prohibit lawmakers from buying individual stocks during their time in office and require at least seven days notice before any sales.
Some Republicans argue that legislators who advocate for sanctions and restrictions on China should face heightened scrutiny over investments in Chinese companies. The debate has extended beyond Suozzi to encompass broader discussions about congressional ethics rules.
What the Left Is Saying
Progressive critics of Suozzi's investment activity say it underscores broader ethical concerns about members of Congress trading stocks while setting policy. Organizations advocating for government accountability have long called for restrictions on legislator stock trading.
The Congressional Uyghur Caucus, which Suozzi co-chairs, has been a vehicle for bipartisan action on human rights abuses in Xinjiang. When relaunching the caucus in 2024, Suozzi said: "What's happening to Uyghur Muslims in Xinjiang should shock everyone's conscience." He described the Chinese Communist Party as "brutally and systemically trying to destroy the Uyghur people with mass internment camps, forced labor, sexual abuse, and forced sterilization."
Defenders of Suozzi note that his advocacy work on Uyghur issues has been consistent and substantive, including co-sponsoring the Uyghur Genocide Accountability and Sanctions Act of 2025. They argue that holding diversified investments in publicly traded companies is common among members of Congress and does not necessarily reflect personal values or policy priorities.
What the Numbers Show
According to congressional financial disclosure reports, Suozzi purchased between $1,001 and $15,000 of NIO stock on September 2, 2020, followed by another purchase of between $15,001 and $50,000 on October 5, 2020. He sold between $15,001 and $50,000 worth of NIO stock on May 20, 2021.
NIO is a Chinese electric vehicle manufacturer that has faced scrutiny over supply chain links allegedly connected to Uyghur forced labor. Suozzi also invested in Baidu, selling between $15,001 and $50,000 of stock in 2017. The company drew criticism after a patent described facial-recognition technology capable of identifying ethnicity, including Uyghurs.
Since entering Congress, Suozzi has reported 671 stock transactions totaling roughly $20.9 million in disclosed trading volume, according to disclosure records compiled by news organizations tracking congressional finances. Approximately half of all members of Congress report trading individual stocks, while the other half report no such trades.
The Bottom Line
Suozzi's case highlights the tension between public advocacy on human rights and private investment decisions involving companies connected to those same issues. His supporters argue his legislative record speaks for itself, while critics question whether investments in scrutinized Chinese firms align with his stated positions on Uyghur rights.
The broader debate over congressional stock trading remains unresolved in Congress. Steil's "Stop Insider Trading Act" has not received a floor vote as of this reporting. Watch for any ethics committee review of Suozzi's disclosures and whether the NIO trading pattern influences ongoing legislative efforts to restrict lawmaker stock transactions.